Why is Makers Laboratories Ltd falling/rising?

Short-Term Price Movement and Market Performance

The stock has demonstrated a strong upward trajectory over the past week, gaining 5.65%, significantly outperforming the Sensex which remained virtually flat with a marginal decline of 0.01%. Year-to-date, Makers Laboratories has delivered a 5.21% return, contrasting with the Sensex’s 1.94% decline. This recent rally is further underscored by the stock’s three consecutive days of gains, accumulating a 7.57% return in that period. Intraday, the share price touched a high of Rs 124.60, marking a 3.75% increase, signalling robust buying interest during the trading session.

Technical indicators show the stock trading above its 5-day, 20-day, and 50-day moving averages, suggesting positive short-term momentum. However, it remains below the 100-day and 200-day moving averages, indicating that longer-term trends have yet to confirm a sustained recovery. Despite the price appreciation, investor participation appears to be waning slightly, with delivery volumes on 14 Jan falling by 11.1% compared to the five-day average, which could imply cautious optimism among shareholders.

Long-Term Performance and Fundamental Concerns

Despite the recent price gains, Makers Laboratories’ long-term performance remains disappointing. Over the past year, the stock has declined by 31.91%, a stark contrast to the Sensex’s 8.47% gain. Over a five-year horizon, the stock has plummeted by 52.81%, while the benchmark index surged 70.43%. This underperformance extends to the three-year period as well, where Makers Laboratories posted an 8.42% return against the Sensex’s 39.07% rise.

Fundamental analysis reveals significant challenges. The company has experienced a negative compound annual growth rate (CAGR) of 19.06% in operating profits over the last five years, signalling deteriorating operational efficiency. Return on equity (ROE) averages a mere 2.20%, indicating low profitability relative to shareholders’ funds. Furthermore, the company reported flat financial results in September 2025, with profits declining by over 100% in the past year, underscoring severe earnings pressure.

Valuation metrics also raise concerns. The stock trades at a price-to-book value of 1, which is considered expensive given the company’s weak profitability and flat ROE. This premium valuation relative to peers’ historical averages suggests that the current price may not fully reflect the underlying financial stress. Consequently, the stock has been classified as a strong sell by some analysts, given its below-par performance both in the near and long term, and its consistent underperformance against the BSE500 index over multiple time frames.

Investor Takeaway

The recent rise in Makers Laboratories Ltd’s share price appears to be driven primarily by short-term market dynamics and technical factors rather than a fundamental turnaround. While the stock has outperformed its sector and the broader market in the past week and year-to-date, these gains come against a backdrop of weak profitability, declining operating profits, and a challenging valuation profile. The falling delivery volumes suggest that investor enthusiasm may be tentative, and the stock remains below key long-term moving averages, signalling caution.

Investors should weigh the short-term price momentum against the company’s persistent financial struggles and underwhelming returns over longer periods. The premium valuation despite poor earnings performance raises questions about sustainability. As such, while the stock’s recent gains are encouraging, they do not yet reflect a fundamental recovery, and investors may want to consider alternative opportunities with stronger business fundamentals and more favourable growth prospects.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →